960 x 350_41

体外筛选

体外筛选在候选药物优化 ADME 特性中发挥关键作用。提前确定最有前景的候选药物可加速开发周期,降低成本,简化药物发现流程,指导后续的临床前和临床研究。Q2 Solutions 高自动化体外 ADME 实验室提供一系列高通量 ADME 筛选服务,以支持药物发现的先导优化阶段,包括代谢稳定性、细胞渗透性测定和抑制细胞色素 P450 酶的风险评估。

我们的 ADME 筛选组件包和 LC/MS 生物分析能力可支持您的体外和药代动力学(PK)检测


q2lab solutions images_0014_Layer 2

早期先导化合物的 ADME 筛选服务包

捆绑筛选检测,以在药物发现中加速候选药物选择

q2lab solutions images_0001_Layer 15

高通量 ADME 服务

加速临床前研究的能力

相关思想领袖见解


Small Molecule Bioanalytical and ADME Solutions

Q2 Solutions offers tailored and comprehensive small molecule bioanalytical and ADME laboratory services. We combine scientific excellence, high-quality project management, and outstanding delivery...

Quantification of the Polydisperse Heparin Analog Dociparstat by Signature Disaccharide Analysis in the Presence of Concomitant Enoxaparin Dosing in Support of a Phase 2/3 Study in Patients with Severe COVID-19

Analysis of a polydisperse heparin analog therapeutic (CX-01, Dociparstat) was conducted in human plasma by signature disaccharide (NS6S) analysis, with NS6S being unique to CX-01 in native human...

Hybrid assays: an interview with Barry Jones and Adriane Spytko

In this podcast Barry Jones (Director, LC–MS Biologics and Biomarkers at Q² Solutions) and Adriane Spytko (Manager, LC–MS Biologics at Q² Solutions; both NY, USA) discuss hybrid assays using both...